ReviewCardiovascular diabetology. Endocrinology reports2026

Concomitant use of SGLT2 inhibitors and GLP-1 receptor agonists in patients with heart failure.

Reza Khademi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.